Top Pharmaceutical Startups in Sweden (2025 Update)
Explore the best Pharmaceutical companies in Sweden. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hi, I'm Bounce Watch. Let's explore what's happening in Top Pharmaceutical Startups in Sweden!
Real-Time Scouting Assistant
Explore Top Pharmaceutical Startups in Sweden featuring 84 Companies
|
|
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Immuneed | - | Select the most promising drug candidates with us and accelerate your path to dr... | Our technology, ID.Flow, utilizes freshly donated human blood to help researcher... | - |
Sweden
|
- | Sweden (HQ) | 2014 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
12
|
1.8K (38%) | 8 years ago | Seed | 1 | 4.3M | 2681 | 5 months ago | |
|
|
|
Oblique Therapeutics AB (... | - | Antibody Magic | Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovati... | - |
Sweden
|
- | Sweden (HQ) | 2015 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
17
|
1.7K (-19%) | 9 years ago | Series Unknown | 1 | 2.5M | 1923 | 6 months ago | |
|
|
|
MEDS Apotek | - | MEDS - A really good pharmacy! MEDS delivers prescription drugs and thousands o... |
MEDS - A really good pharmacy MEDS is an online pharmacy authorized by the Swed... |
- |
Sweden
|
- | Sweden (HQ) | 2017 | E-Commerce, Health Care +2 | [email protected] |
1
Low
|
82
|
2.2M (29%) | 3 years ago | Secondary Market | 7 | 26.0M | 5450 | 5 months ago | |
|
|
|
EMPE Diagnostics | - | Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even... | Globally, 10 million new cases every year and 4000 people die every day due to T... | - |
Sweden
|
- | Sweden (HQ) | 2015 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
27
|
356 (-30%) | 5 years ago | Series A | 3 | 42.9M | 2751 | 1 year ago | |
|
|
|
Acorai | - | The new standard in heart failure management | Acorai is developing a device for heart failure management through non-invasive... | - |
Sweden
|
- | Sweden (HQ) + 1 | 2019 | Health Care, Medical Devices +1 | [email protected] |
1
Low
|
25
|
829 (-100%) | 1 year ago | Non Equity Assistance | 8 | 11.4M | 7630 | 5 months ago | |
|
|
|
Apotekamo | - | Experience seamless online pharmacy solutions, connecting traditional pharmacies... | Apotekamo serves as a virtual drugstore platform that facilitates traditional ph... | - |
Sweden
|
- | Sweden (HQ) | 2018 | B2B, Marketplaces +1 | - |
1
Low
|
116
|
89 (-100%) | 2 years ago | Series Unknown | 4 | 54.5M | 30584 | 3 e6u L1B | |
|
|
|
OnDosis | - | OnDosis is revolutionizing the way patients take their medicines | We believe that everyone deserves a good life, and for some that is only possibl... | - |
Sweden
|
- | Sweden (HQ) | 2017 | Pharmaceutical | - |
1
Low
|
41
|
760 | 4 years ago | Series Unknown | 4 | 14.6M | 1860 | 7 months ago | |
|
|
|
Dicot | - | Dicot is a pharmaceutical company focused on increasing well-being through innov... | Dicot is a pharmaceutical company focused on increasing quality of life and well... | - |
Sweden
|
- | Sweden (HQ) | 2018 | Health Care, Manufacturing +2 | [email protected] |
1
Low
|
7
|
931 (-100%) | 1 year ago | Grant | 1 | 250.0K | 1372 | 11 months ago | |
|
|
|
Modus Therapeutics Holdin... | - | We develop sevuparin to help patients with severe conditions and high unmet medi... | Modus Therapeutics is a Swedish biotech company developing sevuparin for disease... | - |
Sweden
|
- | Sweden (HQ) | 2011 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
4
|
2.2K (29%) | 2 years ago | Post Ipo Debt | 4 | 190.5M | 468 | 5 months ago | |
|
|
|
Anyo Labs | - | We have built the world’s fastest small molecular drug discovery tools, born in... | ANYO Labs is focused on virtual screening and de novo small molecular drug gener... | - |
Sweden
|
- | Sweden (HQ) | 2022 | AI, Biotechnology +3 | [email protected] |
1
Low
|
15
|
453 (-70%) | 1 year ago | Pre Seed | 2 | 300.0K | 832 | 5 months ago | |
|
|
|
Melius Pharma | - | Clinical stage biopharma company developing treatments for diseases with high un... | Melius Pharma is a Swedish clinical stage pharmaceutical company. We develop tre... | - |
Sweden
|
- | Sweden (HQ) | 2021 | Health Care, Pharmaceutical | - |
1
Low
|
3
|
243 | 3 years ago | Series A | 1 | 18.0M | 160 | 1 year ago | |
|
|
|
Calliditas Therapeutics | - | Pioneering treatments for rare diseases. We harness scientific & commercial expe... | Calliditas is a specialty pharmaceutical company developing high value products... | - |
Sweden
|
- | Sweden (HQ) + 4 | 2004 | Biotechnology, Medical Devices +1 | [email protected] |
1
Low
|
242
|
9.4K (15%) | 1 year ago | Post Ipo Debt | 6 | 210.4M | 11789 | 5 months ago | |
|
|
|
Umecrine Cognition AB | - | A novel and safe approach for treating cognitive disorders | Umecrine Cognition is developing a completely new type of drug for neurological... | - |
Sweden
|
- | Sweden (HQ) | 2000 | Biotechnology, Health Care +1 | - |
1
Low
|
11
|
1.8K | 1 year ago | Convertible Note | 3 | 50.4M | 467 | 5 months ago | |
|
|
|
Intervacc AB | - | A new generation of vaccines based on fusions of recombinant proteins |
A new generation of vaccines within animal health We develop vaccines based on... |
- |
Sweden
|
- | Sweden (HQ) | 2001 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
13
|
2.4K (9%) | 1 year ago | Grant | 2 | 30.0M | 687 | 1 year ago | |
|
|
-logo. "Oncopeptides AB (publ)"){kind=logo}
|
Oncopeptides AB (publ) | - | Oncopeptides is a global biotech company focused on research & development of th... | Oncopeptides is a biotech company focusing on research, development and commerci... | - |
Sweden
|
- | Sweden (HQ) + 1 | 2000 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
97
|
8.7K (-4%) | 2 years ago | Grant | 6 | 240.5M | 10109 | 5 months ago | |
|
|
|
PharmNovo | - | Innovation in pain relief | PharmNovo AB is a clinical-stage pharmaceutical company focused on developing sa... | - |
Sweden
|
- | Sweden (HQ) | 2008 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
10
|
860 (-59%) | 10 months ago | Series Unknown | 6 | 31.1M | 735 | 5 months ago | |
|
|
|
Iconovo AB | - | We bring inhalation expertise to your business | Iconovo is a leading Swedish CDMO company, offering innovative and effective inh... | - |
Sweden
|
- | Sweden (HQ) | 2013 | Design, Medical Devices +1 | - |
1
Low
|
39
|
2.2K (38%) | 2 years ago | Grant | 4 | 12.2M | 3149 | 5 months ago | |
|
|
|
NEOGAP Therapeutics AB | - | Science for cure. | NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical comp... | - |
Sweden
|
- | Sweden (HQ) | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
27
|
1.6K (154%) | 1 year ago | Grant | 5 | 19.7M | 1997 | 5 months ago | |
|
|
|
BioInvent International A... | - | BioInvent is translating cancer antibody biology into innovative immuno-oncology... | BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech... | - |
Sweden
|
- | Sweden (HQ) | 1983 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
134
|
334 (-100%) | 2 years ago | Post Ipo Equity | 2 | 5.4M | 7631 | 5 months ago | |
|
|
|
LIPUM AB | - | We have developed a biological drug SOL-116 for treatment of chronic inflammator... | Lipum aims for better quality of life for the millions suffering from chronic in... | - |
Sweden
|
- | Sweden (HQ) | 2010 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
15
|
2.6K (24%) | 1 year ago | Post Ipo Equity | 4 | 11.2M | 2045 | 5 months ago | |
|
|
|
OncoZenge AB | - | Potential to be the leading treatment for oral pain. | OncoZenge är ett svensk läkemedelsbolag som utvecklar en ny behandling för effek... | - |
Sweden
|
- | Sweden (HQ) | 2020 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
4
|
760 | 4 years ago | Seed | 1 | 10.0M | 333 | 2 5f0 KhW | |
|
|
|
Ectin Research | - | Medicine not ´miracle´ MFA-370: a novel therapy eliminating cancer tumors. | Our novel therapy for eliminating cancer tumors, MFA370, will be tested in clini... | - |
Sweden
|
- | Sweden (HQ) | 2013 | Health and Wellness, Pharmaceutical | [email protected] |
1
Low
|
3
|
679 (-100%) | 8 years ago | Grant | 1 | 50.0K | 328 | 1 year ago | |
|
|
|
Camurus | - | Committed to developing and commercializing long-acting treatments for patients... | Camurus is a Swedish science-led biopharmaceutical company committed to improvin... | - |
Sweden
|
- | Sweden (HQ) | 1991 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
240
|
7.9K | 9 years ago | Series Unknown | 1 | 54.0M | 8319 | 5 months ago | |
|
|
|
MetaboGen AB | - | Developing next generation probiotics, based on the gut microbiome | As a pioneering company addressing the microbiome to understand health and disea... | - |
Sweden
|
- | Sweden (HQ) + 1 | 2011 | Pharmaceutical | - |
1
Low
|
2
|
356 | 7 years ago | Corporate Round | 2 | 16.6M | 964 | 2 O5n Ldq | |
|
|
|
Cinclus Pharma | - | Developing effective treatment for gastric acid related diseases. | Cinclus Pharma develops small molecules for the treatment of gastric acid relate... | - |
Sweden
|
- | Sweden (HQ) | 2014 | Biotechnology, Health Care +1 | - |
1
Low
|
20
|
2.0K (-53%) | 3 years ago | Series Unknown | 2 | 490.0M | 1466 | 6 months ago | |
|
|
|
ILYA Pharma | - | Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients | Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients | - |
Sweden
|
- | Sweden (HQ) | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
15
|
365 | 4 years ago | Grant | 6 | 13.6M | 3818 | 2 years ago | |
|
|
|
Ascelia Pharma AB | - | Ascelia Pharma is an oncology-dedicated orphan drug company listed on Nasdaq Sto... | Ascelia Pharma is a biotech company focused on orphan oncology treatments. We de... | - |
Sweden
|
- | Sweden (HQ) | 2000 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
16
|
704 (-56%) | 4 years ago | Post Ipo Equity | 1 | 200.0M | 2346 | 5 months ago | |
|
|
|
Captario | - | A major step-change in drug development: Captario SUM® provides advanced modelin... | Founded in Gothenburg, Sweden, Captario is a software company catering to the ph... | - |
Sweden
|
- | Sweden (HQ) | 2012 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
27
|
670 (-44%) | 6 years ago | Series Unknown | 3 | 50.0M | 3227 | 5 months ago | |
|
|
|
XNK Therapeutics | - | INDIVIDUALIZED NK CELL THERAPIES | XNK Therapeutics is a clinical-stage biotechnology company developing unique and... | - |
Sweden
|
- | Sweden (HQ) | 2012 | Health and Wellness, Pharmaceutical | [email protected] |
1
Low
|
9
|
768 (-100%) | 1 year ago | Grant | 4 | 197.7M | 2834 | 1 year ago | |
|
|
|
Recipharm | - | Your innovation, delivered with certainty. | Recipharm is a leading global CDMO dedicated to meeting your evolving needs thro... | - |
Sweden
|
- | Sweden (HQ) + 16 | 1995 | Biotechnology, Manufacturing +1 | [email protected] |
1
Low
|
3320
|
2715 | - | Post Ipo Equity | - | 241.7M | 86788 | 4 months ago | |
|
|
|
Newbury Pharmaceuticals A... | - | Your local champion and alternative partner | Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rap... | - |
Sweden
|
- | Sweden (HQ) + 1 | 2020 | Pharmaceutical | [email protected] |
1
Low
|
11
|
89661 | - | Post Ipo Equity | - | 19.0M | 1441 | 5 months ago | |
|
|
|
Fluicell | - | Making tissue therapeutics possible to defeat serious disease | Fluicell is transforming how we treat disease with one-of-a-kind tissue solution... | - |
Sweden
|
- | Sweden (HQ) + 1 | 2012 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
16
|
3.8K (27%) | 4 years ago | Post Ipo Equity | 2 | 4.0M | 3333 | 5 months ago | |
|
|
|
Medivir AB | - | Improving life for cancer patients through transformative drugs | Medivir develops innovative drugs with a focus on cancer where the unmet medical... | - |
Sweden
|
- | Sweden (HQ) | 1988 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
46
|
2.0K (144%) | 1 year ago | Post Ipo Equity | 2 | 42.6M | 5932 | 5 months ago | |
|
|
|
Asarina Pharma | - | We're developing Sepranolone, a safe endogenous compound for the treatment of Me... | Asarina Pharma is developing novel and targeted products to treat women with sev... | - |
Sweden
|
- | Sweden (HQ) | 2006 | Biopharma, Biotechnology +2 | - |
1
Low
|
5
|
1.8K (-22%) | 6 years ago | Post Ipo Equity | 4 | 24.8M | 801 | 1 year ago | |
|
|
|
Orexo AB publ | - | Improves lives for patients suffering from mental illness and substance use diso... | Orexo is a Swedish pharmaceutical company with over 25 years of experience devel... | - |
Sweden
|
- | Sweden (HQ) + 1 | 1995 | Biotechnology, Health Care +1 | - |
1
Low
|
97
|
1.8K (-22%) | 1 year ago | Post Ipo Debt | 4 | 121.9M | 4605 | 5 months ago | |
|
|
|
Sciety | - | A leading investment company, committed to supporting the growth of life science... | Sciety is a leading investment company, committed to supporting the growth of in... | - |
Sweden
|
- | Sweden (HQ) | 2014 | Biotechnology, Health Care +3 | [email protected] |
1
Low
|
18
|
2.9K (71%) | 7 years ago | Seed | 1 | 950.0K | 3685 | 5 months ago | |
|
|
|
Cavis Technologies AB | - | Providing a new level of precision in assessment of coronary artery disease. | We are an innovative med-tech company developing, producing and supplying invasi... | - |
Sweden
|
- | Sweden (HQ) | 2015 | Health Care, Pharmaceutical | - |
1
Low
|
3
|
65 | 5 years ago | Seed | 1 | 900.0K | 271 | 1 year ago | |
|
|
|
XSPRAY PHARMA AB (PUBL) | - | www.xspraypharma.com | Xspray Pharma (Nasdaq Stockholm: XSPRAY) aims to improve patients’ quality of li... | - |
Sweden
|
- | Sweden (HQ) | 2003 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
35
|
1.8K (20%) | 6 months ago | Post Ipo Debt | 2 | 100.0M | 1393 | 4 months ago | |
|
|
|
Gesynta Pharma AB | - | - | Gesynta Pharma's drug candidate vipoglanstat (GS-248) is in clinical phase II de... | - |
Sweden
|
- | Sweden (HQ) | 2017 | Biopharma, Health Care +1 | [email protected] |
1
Low
|
14
|
2.0K (33%) | 4 years ago | Series C | 2 | 27.3M | 1167 | 5 months ago | |
|
|
|
Vicore Pharma AB | - | - | Vicore is an innovative clinical-stage pharmaceutical company unlocking the pote... | - |
Sweden
|
- | Sweden (HQ) + 2 | 2009 | Biopharma, Biotechnology +1 | - |
1
Low
|
41
|
3.5K (-58%) | 1 year ago | Post Ipo Equity | 2 | 47.7M | 4954 | 5 months ago |